|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |

| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price | Total Amount |
Shares Ownership |
Filing |
| 2013-05-01 Sale |
2013-05-03 5:36 pm | SANGAMO BIOSCIENCES INC | SGMO | Gregory Philip D (Vice President, Research & CSO) | 6,000 | $10.09 | $60,557 | 90,000 (Direct) | View |
| 2013-04-26 Sale | 2013-04-29 6:16 pm |
SANGAMO BIOSCIENCES INC | SGMO | ANDO DALE G (VP, Therapeutic Dev. & CMO) | 15,000 | $10.72 | $160,746 | 88,798 (Direct) |
View |
| 2013-04-15- -2013-04-16 Sale | 2013-04-19 06:00 am | SANGAMO BIOSCIENCES INC | SGMO | LANPHIER EDWARD O II (President & CEO Director) | 5,190 | $10 | $51,900 | 1,692,952 (Indirect) | View |
| 2013-04-10 Sale |
2013-04-12 4:30 pm |
SANGAMO BIOSCIENCES INC | SGMO | Wolff Henry Ward (Exec VP & CFO) | 10,000 | $10 | $100,000 | 209,219 (Direct) | View |
| 2013-04-01 Sale | 2013-04-03 6:06 pm |
SANGAMO BIOSCIENCES INC | SGMO | Gregory Philip D (Vice President, Research & CSO) | 6,000 | $9.54 | $57,240 | 90,000 (Direct) |
View |
| 2013-03-26 Sale |
2013-03-28 5:44 pm | SANGAMO BIOSCIENCES INC | SGMO | ANDO DALE G (VP, Therapeutic Dev. & CMO) | 15,000 | $9.182 | $137,724 | 88,798 (Direct) |
View |
| 2013-03-01 Sale |
2013-03-01 6:36 pm | SANGAMO BIOSCIENCES INC | SGMO | Gregory Philip D (Vice President, Research & CSO) | 6,000 | $10 | $60,005 | 90,000 (Direct) | View |
| 2013-02-28 Sale | 2013-03-01 6:34 pm | SANGAMO BIOSCIENCES INC | SGMO | Wolff Henry Ward (Exec VP & CFO) | 10,000 | $10 | $100,000 | 209,219 (Direct) |
View |
| 2013-02-28 Sale | 2013-03-01 6:32 pm | SANGAMO BIOSCIENCES INC | SGMO | LANPHIER EDWARD O II (President & CEO Director) | 25,000 | $10 | $250,000 | 1,698,142 (Indirect) |
View |
| 2013-02-26 Sale | 2013-02-28 6:15 pm | SANGAMO BIOSCIENCES INC | SGMO | ANDO DALE G (VP, Therapeutic Dev. & CMO) | 15,000 | $8.64 | $129,600 | 88,798 (Direct) | View |
| 2013-01-28 Sale(A) | 2013-02-28 6:11 pm |
SANGAMO BIOSCIENCES INC | SGMO | ANDO DALE G (VP, Therapeutic Dev. & CMO) | 15,000 | $9.677 | $145,158 | 88,798 (Direct) |
View |
| 2013-02-01 Sale |
2013-02-05 4:15 pm |
SANGAMO BIOSCIENCES INC | SGMO | Gregory Philip D (Vice President, Research & CSO) | 6,000 | $9.533 | $57,195 | 90,000 (Direct) |
View |
| 2012-01-28 Sale | 2013-01-30 4:17 pm |
SANGAMO BIOSCIENCES INC | SGMO | ANDO DALE G (VP, Therapeutic Dev. & CMO) | 15,000 | $9.677 | $145,158 | 88,798 (Direct) | View |
| 2013-01-23 Sale |
2013-01-28 06:01 am | SANGAMO BIOSCIENCES INC | SGMO | Wolff Henry Ward (Exec VP & CFO) | 10,000 | $10 | $100,000 | 209,219 (Direct) |
View |
| 2013-01-23- -2013-01-24 Sale |
2013-01-28 06:01 am | SANGAMO BIOSCIENCES INC | SGMO | LANPHIER EDWARD O II (President & CEO Director) | 8,600 | $10 | $86,008 | 1,723,142 (Indirect) |
View |
| 2013-01-02 Sale | 2013-01-04 6:14 pm | SANGAMO BIOSCIENCES INC | SGMO | Gregory Philip D (Vice President, Research & CSO) | 6,000 | $6.05 | $36,300 | 90,000 (Direct) | View |
| 2012-12-26 Sale | 2012-12-28 4:06 pm |
SANGAMO BIOSCIENCES INC | SGMO | ANDO DALE G (VP, Therapeutic Dev. & CMO) | 17,000 | $5.925 | $100,718 | 88,798 (Direct) | View |
| 2012-12-10 Sale |
2012-12-10 8:40 pm |
SANGAMO BIOSCIENCES INC | SGMO | Gregory Philip D (Vice President, Research & CSO) | 24,000 | $5.46 | $131,040 | 90,000 (Direct) |
View |
| 2012-12-03 Sale |
2012-12-05 6:06 pm |
SANGAMO BIOSCIENCES INC | SGMO | LARSON JOHN WILLIAM (Director) | 15,000 | $5.642 | $84,634 | 208,160 (Direct) |
View |
| 2012-11-26- -2012-11-27 Sale | 2012-11-28 7:35 pm |
SANGAMO BIOSCIENCES INC | SGMO | ANDO DALE G (VP, Therapeutic Dev. & CMO) | 19,736 | $5.535 | $109,232 | 55,798 (Direct) | View |
| 2012-11-01 Sale | 2012-11-05 6:15 pm |
SANGAMO BIOSCIENCES INC | SGMO | LARSON JOHN WILLIAM (Director) | 15,000 | $5.518 | $82,764 | 223,160 (Direct) |
View |
| 2012-10-26 Sale |
2012-10-29 9:53 pm | SANGAMO BIOSCIENCES INC | SGMO | ANDO DALE G (VP, Therapeutic Dev. & CMO) | 20,000 | $5.697 | $113,935 | 58,534 (Direct) | View |
| 2012-10-17 Sale | 2012-10-17 9:05 pm | SANGAMO BIOSCIENCES INC | SGMO | Gregory Philip D (VP, Therapeutic Dev. & CMO) | 6,000 | $6 | $36,000 | 50,000 (Direct) |
View |
| 2012-10-15 Sale | 2012-10-17 5:58 pm |
SANGAMO BIOSCIENCES INC | SGMO | ANDO DALE G (VP, Therapeutic Dev. & CMO) | 5,000 | $5.657 | $28,283 | 63,534 (Direct) | View |
| 2012-10-01 Sale |
2012-10-03 5:51 pm |
SANGAMO BIOSCIENCES INC | SGMO | LARSON JOHN WILLIAM (Director) | 15,000 | $6.202 | $93,035 | 238,160 (Direct) | View |
| 2012-09-05 Sale |
2012-09-06 5:51 pm | SANGAMO BIOSCIENCES INC | SGMO | ANDO DALE G (VP, Therapeutic Dev. & CMO) | 15,000 | $5.6 | $84,000 | 68,534 (Direct) | View |
| 2012-09-04 Sale | 2012-09-06 5:46 pm | SANGAMO BIOSCIENCES INC | SGMO | LARSON JOHN WILLIAM (Director) | 15,000 | $5.3 | $79,494 | 253,160 (Direct) |
View |
| 2012-08-27 Sale | 2012-08-29 7:07 pm |
SANGAMO BIOSCIENCES INC | SGMO | ANDO DALE G (VP, Therapeutic Dev. & CMO) | 5,000 | $5.181 | $25,903 | 68,534 (Direct) | View |
| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price |
Total Amount | Shares Ownership | Filing |
| 2013-05-07 Exercise |
2013-05-09 4:50 pm |
SANGAMO BIOSCIENCES INC | SGMO | LARSON JOHN WILLIAM (Director) | 10,000 | $2.45 | $24,500 | 218,160 (Direct) |
View |
| 2013-05-01 Exercise |
2013-05-03 5:36 pm |
SANGAMO BIOSCIENCES INC | SGMO | Gregory Philip D (Vice President, Research & CSO) | 6,000 | $3.45 | $20,700 | 96,000 (Direct) | View |
| 2013-04-26 Exercise |
2013-04-29 6:16 pm | SANGAMO BIOSCIENCES INC | SGMO | ANDO DALE G (VP, Therapeutic Dev. & CMO) | 15,000 | $3.61 | $54,150 | 103,798 (Direct) | View |
| 2013-03-28 Gift | 2013-04-19 06:00 am |
SANGAMO BIOSCIENCES INC | SGMO | LANPHIER EDWARD O II (President & CEO Director) | 12,000 | $0 | $0 | 1,680,952 (Indirect) |
View |
| 2013-04-10 Option Award | 2013-04-12 4:30 pm |
SANGAMO BIOSCIENCES INC | SGMO | Wolff Henry Ward (Exec VP & CFO) | 10,000 | $3.45 | $34,500 | 219,219 (Direct) | View |
| 2013-04-01 Exercise |
2013-04-03 6:06 pm |
SANGAMO BIOSCIENCES INC | SGMO | Gregory Philip D (Vice President, Research & CSO) | 6,000 | $3.45 | $20,700 | 96,000 (Direct) |
View |
| 2013-03-26 Exercise |
2013-03-28 5:44 pm | SANGAMO BIOSCIENCES INC | SGMO | ANDO DALE G (VP, Therapeutic Dev. & CMO) | 15,000 | $3.61 | $54,150 | 103,798 (Direct) |
View |
| 2013-03-01 Exercise |
2013-03-01 6:36 pm |
SANGAMO BIOSCIENCES INC | SGMO | Gregory Philip D (Vice President, Research & CSO) | 6,000 | $4.92 | $29,520 | 96,000 (Direct) | View |
| 2013-02-28 Exercise | 2013-03-01 6:34 pm | SANGAMO BIOSCIENCES INC | SGMO | Wolff Henry Ward (Exec VP & CFO) | 10,000 | $3.45 | $34,500 | 219,219 (Direct) | View |
| 2013-02-26 Exercise | 2013-02-28 6:15 pm | SANGAMO BIOSCIENCES INC | SGMO | ANDO DALE G (VP, Therapeutic Dev. & CMO) | 15,000 | $3.61 | $54,150 | 103,798 (Direct) |
View |
| 2013-01-28 Exercise(A) | 2013-02-28 6:11 pm | SANGAMO BIOSCIENCES INC | SGMO | ANDO DALE G (VP, Therapeutic Dev. & CMO) | 15,000 | $3.61 | $54,150 | 103,798 (Direct) | View |
| 2013-02-01 Exercise |
2013-02-05 4:15 pm | SANGAMO BIOSCIENCES INC | SGMO | Gregory Philip D (Vice President, Research & CSO) | 6,000 | $4.92 | $29,520 | 96,000 (Direct) | View |
| 2012-01-28 Exercise | 2013-01-30 4:17 pm | SANGAMO BIOSCIENCES INC | SGMO | ANDO DALE G (VP, Therapeutic Dev. & CMO) | 15,000 | $3.61 | $54,150 | 103,798 (Direct) | View |
| 2013-01-23 Option Award | 2013-01-28 06:01 am | SANGAMO BIOSCIENCES INC | SGMO | Wolff Henry Ward (Exec VP & CFO) | 8,000 | $3.45 | $27,600 | 219,219 (Direct) | View |
| 2013-01-02 Exercise |
2013-01-04 6:14 pm |
SANGAMO BIOSCIENCES INC | SGMO | Gregory Philip D (Vice President, Research & CSO) | 6,000 | $4.92 | $29,520 | 96,000 (Direct) |
View |
| 2012-12-26 Exercise |
2012-12-28 4:06 pm |
SANGAMO BIOSCIENCES INC | SGMO | ANDO DALE G (VP, Therapeutic Dev. & CMO) | 15,000 | $3.61 | $54,150 | 103,798 (Direct) | View |
| 2012-12-06 Option Award |
2012-12-10 8:40 pm | SANGAMO BIOSCIENCES INC | SGMO | Gregory Philip D (Vice President, Research & CSO) | 40,000 | $0 | $0 | 90,000 (Direct) | View |
| 2012-06-13- -2012-12-06 Gift Option Award |
2012-12-10 8:39 pm |
SANGAMO BIOSCIENCES INC | SGMO | LANPHIER EDWARD O II (President & CEO Director) | 191,000 | $0 | $0 | 1,559,742 (Direct Indirect) |
View |
| 2012-12-06 Option Award | 2012-12-10 8:33 pm | SANGAMO BIOSCIENCES INC | SGMO | ANDO DALE G (VP, Therapeutic Dev. & CMO) | 35,000 | $0 | $0 | 90,798 (Direct) | View |
| 2012-12-06 Option Award |
2012-12-10 8:31 pm |
SANGAMO BIOSCIENCES INC | SGMO | Wolff Henry Ward (Exec VP & CFO) | 45,000 | $0 | $0 | 211,219 (Direct) |
View |
| 2012-12-06 Option Award | 2012-12-10 8:28 pm | SANGAMO BIOSCIENCES INC | SGMO | NICHOL GEOFFREY (Executive Vice President, R&D) | 55,000 | $0 | $0 | 130,000 (Direct) | View |
| 2012-11-27 Exercise | 2012-11-28 7:35 pm | SANGAMO BIOSCIENCES INC | SGMO | ANDO DALE G (VP, Therapeutic Dev. & CMO) | 15,000 | $3.61 | $54,150 | 70,798 (Direct) | View |
| 2012-10-26 Exercise |
2012-10-29 9:53 pm | SANGAMO BIOSCIENCES INC | SGMO | ANDO DALE G (VP, Therapeutic Dev. & CMO) | 15,000 | $3.61 | $54,150 | 78,534 (Direct) | View |
| 2012-10-17 Exercise | 2012-10-17 9:05 pm |
SANGAMO BIOSCIENCES INC | SGMO | Gregory Philip D (VP, Therapeutic Dev. & CMO) | 6,000 | $4.92 | $29,520 | 56,000 (Direct) |
View |
| 2012-09-05 Exercise |
2012-09-06 5:51 pm |
SANGAMO BIOSCIENCES INC | SGMO | ANDO DALE G (VP, Therapeutic Dev. & CMO) | 15,000 | $3.61 | $54,150 | 83,534 (Direct) | View |
| 2011-12-08 Option Award | 2011-12-12 8:53 pm |
SANGAMO BIOSCIENCES INC | SGMO | Ichikawa David G (Senior VP, Bus. Dev.) | 25,000 | $0 | $0 | 25,000 (Direct) |
View |
| Transaction & Date |
Reported Date | Exercisable Expiration |
Company | Symbol | Insider Relationship |
Shares Traded | Conversion Price | Shares Ownership |
Filing |
| 2013-05-07 Exercise |
2013-05-09 4:50 pm |
2004-05-14 2013-05-13 | SANGAMO BIOSCIENCES INC | SGMO | LARSON JOHN WILLIAM (Director) | 10,000 | $2.45 | 0 (Direct) |
View |
| 2013-05-01 Exercise | 2013-05-03 5:36 pm |
N/A 2018-12-09 |
SANGAMO BIOSCIENCES INC | SGMO | Gregory Philip D (Vice President, Research & CSO) | 6,000 | $3.45 | 129,709 (Direct) |
View |
| 2013-04-26 Exercise |
2013-04-29 6:16 pm |
N/A 2014-08-01 |
SANGAMO BIOSCIENCES INC | SGMO | ANDO DALE G (VP, Therapeutic Dev. & CMO) | 15,000 | $3.61 | 65,000 (Direct) |
View |
| 2013-04-10 Exercise | 2013-04-12 4:30 pm | N/A 2018-12-09 | SANGAMO BIOSCIENCES INC | SGMO | Wolff Henry Ward (Exec VP & CFO) | 10,000 | $3.45 | 272,000 (Direct) | View |
| 2013-04-01 Exercise |
2013-04-03 6:06 pm | N/A 2018-12-09 | SANGAMO BIOSCIENCES INC | SGMO | Gregory Philip D (Vice President, Research & CSO) | 6,000 | $3.45 | 135,709 (Direct) | View |
| 2013-03-26 Exercise |
2013-03-28 5:44 pm |
N/A 2014-08-01 |
SANGAMO BIOSCIENCES INC | SGMO | ANDO DALE G (VP, Therapeutic Dev. & CMO) | 5,800 | $3.61 | 0 (Direct) |
View |
| 2013-03-26 Exercise | 2013-03-28 5:44 pm |
N/A 2014-08-01 |
SANGAMO BIOSCIENCES INC | SGMO | ANDO DALE G (VP, Therapeutic Dev. & CMO) | 9,200 | $3.61 | 80,000 (Direct) |
View |
| 2013-03-01 Exercise |
2013-03-01 6:36 pm | N/A 2013-12-01 |
SANGAMO BIOSCIENCES INC | SGMO | Gregory Philip D (Vice President, Research & CSO) | 6,000 | $4.92 | 3,000 (Direct) | View |
| 2013-02-28 Exercise | 2013-03-01 6:34 pm |
N/A 2018-12-09 | SANGAMO BIOSCIENCES INC | SGMO | Wolff Henry Ward (Exec VP & CFO) | 10,000 | $3.45 | 282,000 (Direct) | View |
| 2013-02-26 Exercise | 2013-02-28 6:15 pm | N/A 2014-08-01 |
SANGAMO BIOSCIENCES INC | SGMO | ANDO DALE G (VP, Therapeutic Dev. & CMO) | 15,000 | $3.61 | 5,800 (Direct) |
View |
| 2013-01-28 Exercise |
2013-02-28 6:11 pm | N/A 2014-08-01 |
SANGAMO BIOSCIENCES INC | SGMO | ANDO DALE G (VP, Therapeutic Dev. & CMO) | 15,000 | $3.61 | 20,800 (Direct) |
View |
| 2013-02-01 Exercise |
2013-02-05 4:15 pm |
N/A 2013-12-01 |
SANGAMO BIOSCIENCES INC | SGMO | Gregory Philip D (Vice President, Research & CSO) | 6,000 | $4.92 | 9,000 (Direct) |
View |
| 2012-01-28 Exercise | 2013-01-30 4:17 pm |
N/A 2014-08-01 | SANGAMO BIOSCIENCES INC | SGMO | ANDO DALE G (VP, Therapeutic Dev. & CMO) | 15,000 | $3.61 | 20,800 (Direct) | View |
| 2013-01-23 Exercise |
2013-01-28 06:01 am |
N/A 2018-12-09 |
SANGAMO BIOSCIENCES INC | SGMO | Wolff Henry Ward (Exec VP & CFO) | 8,000 | $3.45 | 292,000 (Direct) | View |
| 2013-01-02 Exercise |
2013-01-04 6:14 pm |
N/A 2013-01-02 | SANGAMO BIOSCIENCES INC | SGMO | Gregory Philip D (Vice President, Research & CSO) | 6,000 | $4.92 | 15,000 (Direct) | View |
| 2012-12-26 Exercise |
2012-12-28 4:06 pm | N/A 2014-08-01 |
SANGAMO BIOSCIENCES INC | SGMO | ANDO DALE G (VP, Therapeutic Dev. & CMO) | 15,000 | $3.61 | 35,800 (Direct) | View |
| 2012-12-06 Option Award | 2012-12-10 8:40 pm | N/A 2022-12-05 | SANGAMO BIOSCIENCES INC | SGMO | Gregory Philip D (Vice President, Research & CSO) | 80,000 | $5.41 | 80,000 (Direct) |
View |
| 2012-12-10 Exercise | 2012-12-10 8:40 pm |
N/A 2013-12-02 | SANGAMO BIOSCIENCES INC | SGMO | Gregory Philip D (Vice President, Research & CSO) | 12,000 | $4.92 | 21,000 (Direct) | View |
| 2012-12-06 Option Award | 2012-12-10 8:39 pm |
N/A 2022-12-05 | SANGAMO BIOSCIENCES INC | SGMO | LANPHIER EDWARD O II (President & CEO Director) | 250,000 | $5.41 | 250,000 (Direct) | View |
| 2012-12-06 Option Award |
2012-12-10 8:33 pm | N/A 2022-12-05 | SANGAMO BIOSCIENCES INC | SGMO | ANDO DALE G (VP, Therapeutic Dev. & CMO) | 70,000 | $5.41 | 70,000 (Direct) |
View |
| 2012-12-06 Option Award | 2012-12-10 8:31 pm |
N/A 2022-12-05 | SANGAMO BIOSCIENCES INC | SGMO | Wolff Henry Ward (Exec VP & CFO) | 90,000 | $5.41 | 90,000 (Direct) |
View |
| 2012-12-06 Option Award |
2012-12-10 8:28 pm |
N/A 2022-12-05 | SANGAMO BIOSCIENCES INC | SGMO | NICHOL GEOFFREY (Executive Vice President, R&D) | 110,000 | $5.41 | 110,000 (Direct) |
View |
| 2012-11-27 Exercise |
2012-11-28 7:35 pm | N/A 2014-08-01 | SANGAMO BIOSCIENCES INC | SGMO | ANDO DALE G (VP, Therapeutic Dev. & CMO) | 15,000 | $3.61 | 50,800 (Direct) | View |
| 2012-10-26 Exercise | 2012-10-29 9:53 pm | N/A 2014-08-01 |
SANGAMO BIOSCIENCES INC | SGMO | ANDO DALE G (VP, Therapeutic Dev. & CMO) | 15,000 | $3.61 | 65,800 (Direct) | View |
| 2012-10-17 Exercise | 2012-10-17 9:05 pm |
N/A 2013-12-02 |
SANGAMO BIOSCIENCES INC | SGMO | Gregory Philip D (VP, Therapeutic Dev. & CMO) | 6,000 | $4.92 | 33,000 (Direct) | View |
| 2012-09-05 Exercise |
2012-09-06 5:51 pm | N/A 2014-08-01 |
SANGAMO BIOSCIENCES INC | SGMO | ANDO DALE G (VP, Therapeutic Dev. & CMO) | 15,000 | $3.61 | 80,800 (Direct) | View |
| 2012-06-21 Option Award |
2012-06-25 7:51 pm | N/A 2022-06-20 |
SANGAMO BIOSCIENCES INC | SGMO | Ramasastry Saira (Director) | 50,000 | $5.03 | 50,000 (Direct) |
View |
| 2012-06-21 Option Award |
2012-06-25 7:45 pm |
N/A 2022-06-20 |
SANGAMO BIOSCIENCES INC | SGMO | Cleveland Paul B (Director) | 10,000 | $5.03 | 10,000 (Direct) |
View |
| 2012-06-21 Option Award |
2012-06-25 6:16 pm | N/A 2022-06-20 | SANGAMO BIOSCIENCES INC | SGMO | DILLY STEPHEN GEORGE (Director) | 10,000 | $5.03 | 10,000 (Direct) |
View |
| 2012-06-21 Option Award |
2012-06-25 6:12 pm |
N/A 2022-06-20 | SANGAMO BIOSCIENCES INC | SGMO | RINGO WILLIAM R (Director) | 10,000 | $5.03 | 10,000 (Direct) | View |
| 2012-06-21 Option Award |
2012-06-25 6:05 pm |
N/A 2022-06-20 |
SANGAMO BIOSCIENCES INC | SGMO | Mento Steven J (Director) | 10,000 | $5.03 | 10,000 (Direct) | View |
| 2011-06-01 Option Award |
2011-06-03 5:33 pm |
N/A 2021-05-31 | SANGAMO BIOSCIENCES INC | SGMO | WIGGANS THOMAS G (Director) | 10,000 | $6.41 | 10,000 (Direct) | View |
|
© 2005-2013 SecForm4.Com All rights reserved. Archives: 2013 2012 2011 2010 2009 2008 ... Sat, 25 May 2013 06:52:36 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |